John Rountree discusses, on CNBC, Novartis financial results, pharma innovation and how acquisitions in Big Pharma are still a hot topic
To read our insight on breakthrough innovation click here and for our point of view on the cost of pharma M&A click here
I agree to Novasecta’s privacy policy (required)
Media
Novartis, innovation and acquisitions in Big Pharma (CNBC)
John Rountree discusses, on CNBC, Novartis financial results, pharma innovation and how acquisitions in Big Pharma are still a hot topic
To read our insight on breakthrough innovation click here and for our point of view on the cost of pharma M&A click here
Related
Media
How Pharma Manages Organisational Complexity (MedNous)
DiscoverHow R&D Teams Create Value from On-Market Products (MedNous)
DiscoverHow European MidPharmas have Grown Profits (MedNous)
Discover